Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Personalized Medicine Market Size, Value And Growth Trajectory Through 2030
The personalized medicine market has experienced significant growth in recent years. It is projected to expand from $422.9 billion in 2025 to $469.11 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. The historical growth of this market can be attributed to the rising prevalence of chronic diseases, advancements in genetic sequencing, increased healthcare expenditure, growing awareness of personalized medicine, and the early adoption of digital health solutions.
The personalized medicine market is projected to undergo significant expansion in the upcoming years. Its valuation is set to reach $733.27 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.8%. This projected growth is driven by several factors, including the incorporation of AI into diagnostics and therapeutics, the broadening scope of gene and cell therapy offerings, the increasing demand for remote patient monitoring, the creation of precise nutrition solutions, and the rising uptake of companion diagnostics. Key trends expected in this period encompass personalized genetic profiling, targeted drug development, patient-focused care models, remote health monitoring, and preventive therapies based on lifestyle.
Get A Free Sample Report With In-Depth Market Insights:
Personalized Medicine Market Growth Factors Behind Sustained Expansion
The increasing number of individuals with obesity is projected to fuel the expansion of the personalized medicine market in the future. Obesity is characterized by an unhealthy or excessive build-up of body fat that can detrimentally affect a person’s well-being. Personalized medicine plays a role in targeting the unique genetic and molecular elements linked to obesity, thus providing customized and efficient treatments for patients. For example, data from December 2024, provided by the Office for Health Improvement and Disparities, a UK-based government department, indicated that the percentage of women recorded as obese in early pregnancy rose from 25.4% between 2022 to 2023 to 26.2% between 2023 to 2024. Consequently, the expanding obese demographic is serving as a catalyst for the development of the personalized medicine market.
Personalized Medicine Market Segmentation And Category Overview
The personalized medicine market covered in this report is segmented –
1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users
Subsegments:
1) By Personalized Medicine Diagnostics: Genetic Testing, Biomarker Testing, Companion Diagnostics, Molecular Imaging
2) By Personalized Medicine Therapeutics: Targeted Therapies, Gene Therapies, Monoclonal Antibodies, Cell and Gene Therapy Products
3) By Personalized Medical Care: Tailored Treatment Plans, Patient-Centric Care Models, Digital Health Solutions, Remote Patient Monitoring
4) By Personalized Nutrition And Wellness: Nutrigenomics, Customized Diet Plans, Supplement Personalization, Lifestyle Modification Programs
Personalized Medicine Market Industry Trends Fueling Future Revenue Growth
Leading companies within the personalized medicine market are concentrating on creating technological advancements, such as artificial intelligence (AI)-powered platforms, to improve diagnosis accuracy, individualize treatment, and increase clinical trial efficiency. These AI-powered platforms employ extensive data analysis to yield practical insights into disease development, patient reactions, and the effectiveness of various treatments. For instance, in April 2023, OM1, a US-based healthcare company that utilizes real-world data and AI, patented an AI-powered platform intended to accelerate personalized medicine. The platform facilitates customized healthcare advice, supports healthcare providers in making informed decisions, and speeds up clinical trials by effectively identifying suitable patient candidates. By incorporating AI-driven analytics into healthcare operations, this technology advances personalized medicine and strengthens market expansion.
Personalized Medicine Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the personalized medicine market are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.
View The Full Personalized Medicine Market Report:
Personalized Medicine Market Regional Outlook: Where Is Opportunity Concentrated?
North America was the largest region in the personalized medicine market in 2025. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
